Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I6KU
|
|||
| Former ID |
DNC013722
|
|||
| Drug Name |
5-(2-m-tolylethynyl)pyrimidine
|
|||
| Synonyms |
5-(M-Tolylethynyl)Pyrimidine; CHEMBL508497; 5-(2-m-tolylethynyl)pyrimidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H10N2
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)C#CC2=CN=CN=C2
|
|||
| InChI |
1S/C13H10N2/c1-11-3-2-4-12(7-11)5-6-13-8-14-10-15-9-13/h2-4,7-10H,1H3
|
|||
| InChIKey |
WDWDORGIXVCIQC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5... Bioorg Med Chem Lett. 2008 Jul 15;18(14):4098-101. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.